A reliable measure to predict peripheral blood progenitor cell (PBPC)
autograft CD34(+) cell content is required to optimize the timing of P
BPC collection. We prospectively examined the peripheral blood (PB) CD
34(+) cell count in 59 consecutive patients with various malignancies
and analyzed the correlation between the PB CD34(+) cell count and var
ious parameters in the PBPC: autograft, Two hundred and thirty-five co
llections were performed with a median of 4.0 collections per patient
(range, 2-10). The median PB CD34(+) cell count at the time of collect
ion was 39 x 10(6)/l (range, 0.0-285.6), The PBPC autograft parameters
measured a ere the CD34(+) cell, colony-forming unit granulocyte-macr
ophage (CFU-GM) and mononuclear cell (MNC) content. There was a strong
linear correlation between PB CD34(+) cells/l and autograft CD34(+) c
ells/kg (I = 0.8477), The correlation with CFU-GM/kg (r = 0.5512) was
weaker. There was no correlation between autograft CD34(+) cells/kg an
d PB WBC (I = 0.0684), PB MNC (r = 0.1518) or PIE platelet count (r =
0.2010), At our institution we aim to obtain a minimum of 0.5 x 10(6)
CD34(+) cells/kg with each day of collection. We demonstrate that such
a collection call be reliably obtained if the PB CD34(+) cell count e
xceeds 5.0 x 10(6)/l.